Biomarker Challenge #2: Analysis of Complex Data More accurate, predictive biomarker analysis may assist in the selection of effective combinatorial immunotherapy treatments for patients. Additionally, the complexity of both the tumor and tumor microenvironment suggests a comprehensive approach is needed for robust characterization of the cancer ecosystem. The ImmunoID NeXT™ platform investigates key aspects [...]
Challenge #1: Comprehensive Biology from a Limited & Difficult Sample More accurate, predictive biomarker analysis may assist in the selection of effective combinatorial immunotherapy treatments for patients. Additionally, the complexity of both the tumor and tumor microenvironment suggests a comprehensive approach is needed for robust characterization of the cancer ecosystem. The ImmunoID NeXTTM [...]
Xtalks Webinar Neoantigens for Personalized Cancer Vaccines-Comprehensive Identification and Effective Selection Developing effective personalized cancer vaccines depends on comprehensively detecting all neoantigens in a tumor sample and then selecting the neoantigens that are most likely to be effective in an individual patient. This process, especially under the timeline demands of clinical trials or [...]
ACE ImmunoID for Biomarker Discovery Maximize your data for translational research. ACE ImmunoID integrates exome and transcriptome data to provide insights into: Mechanisms of immune escape The tumor microenvironment, and Tumor-specific neoantigens
Xtalks webinar: Overcoming the Challenges of Immuno-Oncology Biomarker Discovery From Sample to Analytics Only 20% of patients respond to cancer immunotherapies and determining which patients will respond to which treatment options relies on the identification of predictive biomarkers. Immuno-oncology biomarkers such as tumor mutational burden (TMB) or PD-L1 expression are promising, but have [...]
This online seminar will outline a target enrichment technology to improve next generation sequencing assays for cancer research.
Augmented Exome Sequencing Provides Improved Coverage in Medically Interpretable Genes.
GenomeWeb: Comprehensive Tumor Characterization for Immuno Oncology, Clinical Trials, and Cancer Research This GenomeWeb seminar outlines a targeted enrichment technology to improve next-generation sequencing assays for cancer research and clinical applications. Presenters: Richard Chen, MD and Michael James Clark, PhD More Info: NGS is increasingly being used to support cancer clinical trials, translational [...]
ACE Augmentation Achieves High-Sensitivity for Clinical Applications Heather Wetzel, MS, LCGC discusses the recent publication in Genome Medicine entitled "Achieving high-sensitivity for clinical applications using augmented exome sequencing". Heather will review the results from this first ever comparison of an augmented exome sequencing approach (ACE Clinical Exome) to other standard exomes and whole [...]
AMP Webinar: Achieving High Diagnostic Yield for Clinically Relevant Genes Heather Wetzel, MS, LCGC discusses the recent publication in Genome Medicine entitled "Achieving highsensitivity for clinical applications using augmented exome sequencing". Heather discusses the results from this first ever comparison of an augmented exome sequencing approach (ACE Clinical Exome) to other standard exomes [...]